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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Formerly, Taiwan’s diabetic population has been estimated by surveys
conducted at irregular intervals and using different sampling methods. To obtain nationwide
data on the incidence and prevalence of diabetes mellitus (DM) in Taiwan, we performed an
analysis of the 2000e2009 claim data from the National Health Insurance (NHI) database.
Methods: One-third of the claims in the NHI database from 2000 to 2009 were randomly
sampled. DM was defined by three or more outpatient visits with diagnostic codes (ICD-9-
CM: 250 or A code: A181) within 1 year or by one inpatient discharge diagnosis of DM. Confir-
mation of type 1 diabetes mellitus was based on the issue of a catastrophic illness certificate
with the same diagnostic codes. Age and/or gender distribution for DM were determined.
Results: In accordance with the global trend for DM, with a near constant standardized inci-
dence rate, there was a more than 70% increase in the total diabetic population, or a 35%
increase in the standardized prevalence rate, in Taiwan from 2000 to 2009. The incidence of
diabetes was higher in men, especially in the 20e59-year-old age group, and the total number
of men with diabetes exceeded the number of women with diabetes in 2005. However, the
prevalence and incidence rates in women over the age of 60 years were higher than those
in men. Type 1 DM was present in less than 1% of the diabetic population in Taiwan.
Conclusion: The incidence of diabetes, including type 1, remained stable over this 10-year
period in Taiwan. However, the incidence rate in men aged 20e59 years was higher than that
in age-matched women. With our nationwide database, subgroup analysis of DM incidence canof Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan.
tw (L.-M. Chuang).
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600 Y.-D. Jiang et al.Table 1 Diabetes population an
Year 2
Residents (104) 2
Residents in NHI (%) 9
Total DM (104) 7
Women (104) 3
Men (104) 3
Residents (104) 20e79 y/o 1
Prevalence (%) 20e79 y/o 4
Standardized Prevalence (%) 3
* Underestimated due to incomplebe performed to refine our health policies for the prevention, screening, and treatment of dia-
betes mellitus.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Diabetes mellitus (DM) is an epidemic disease worldwide.
The International Diabetes Federation (IDF) has estimated
that the global diabetic population was 151 million in 2000,
194 million in 2003, 246 million in 2006, 286 million in 2009,
and 366 million in 2011, and this population is expected to
be 552 million in 2030.1 Given such rapid growth, DM is not
only a medical or health issue, but also a social and finan-
cial problem for most governments. Consequently, World
Diabetes Day was declared an official United Nations Day in
2007 with the passage of UN Resolution 61/225 in December
2006.2
On the first UN World Diabetes Day, November 14, 2007,
a committee of Taiwan’s diabetes societies announced the
Taiwan Diabetes Declaration (TDD),3 which was sent to the
IDF president at the United Nations Secretariat Building,
New York City, USA. Several epidemiological surveys were
performed in different areas of Taiwan between 1985 and
1996.4e12 The prevalence of DM varied according to
sampling and inclusion criteria,13 and small sample sizes
also limited the accuracy of the nationwide findings. In
2002, there was a nationwide survey for hyperglycemia,
hypertension, and dyslipidemia (3 Highs) by the Bureau of
Health Promotion that showed that the prevalence of DM
was 8% in individuals older than 19 years of age.14,15 It is
difficult to reproduce such a large survey at a regular
intervals by using traditional field survey methods. We need
to create a national representative survey that can be
updated at short regular intervals.
Taiwan’s National Health Insurance began in 1995 and
covered 99.6% of Taiwan’s residents by 2009. Such a high
coverage rate made the NHI database the best national
indicator of health issues and easier to update annually. An
integrated program was started in 2010 to apply and analyze
the data on various diseases included in this database,
including the relevant incidence, prevalence, mortality
rate, medications used, accountability, cost, complications,
and comorbidities. On the basis of this detailed information,d prevalence rate in Taiwan fro
000 2001 2002 2003
228 2241 2252 2261
6.1 96.6 97.1 97.3
0.7 74.8 81.3 86.8
6.3 38.1 41.1 43.7
4.3 36.6 40.1 43.0
540 1565 1589 1610
.31 4.47 4.76 5.00
.15 3.24 3.42 3.55




A universal compulsory national health insurance (NHI)
program was launched by the Taiwanese government in
March 1995. It provided coverage for 96% of the total
population of Taiwan (23 million) in 2000, 98% in 2005, and
99.6% in 2009. Extensive computerized administrative and
claims data sets derived from this program have been
maintained on an ongoing basis by the National Health
Research Institute (NHRI) of Taiwan and are made available
to investigators for research purposes after de-identifying
individual health information.16 In this study, data sets from
inpatient and outpatient claims from 2000 to 2009 were
used. This study was approved by the institutional review
board of National Taiwan University Hospital.
Case selection
We searched the Taiwan NHI database for the source pop-
ulation from 2000 to 2009 and identified any hospitalization
with diabetes as one of the discharge or outpatient diag-
nostic codes (as per the The International Classification of
Diseases, 9th Revision, Clinical Modification, ICD-9-CM code
250). The A code A181 was used before June 2000 for
outpatients only. To protect personal privacy, NHRI only
provided a random sampling of one-third of the patients
identified as having a hospitalization or ambulatory visit for
diabetes from 2000 to 2009. Patients were classified as
diabetic and were included in our analysis if they had at
least one admission code or three or more outpatient codes
for diabetes within 365 calendar days.17 To avoid the
inclusion of false-positive patients, we used the selection
method used for diabetes for the data from each year.m 2000 to 2009.
2004 2005 2006 2007 2008 2009*
2269 2277 2288 2296 2304 2312
97.6 98.0 98.3 99.3 99.5 99.6
94.5 100.0 105.5 112.8 120.5 122.3*
47.2 49.8 52.5 56.0 59.5 60.2*
47.1 50.1 53.0 56.8 61.0 62.1*
1631 1649 1665 1681 1699 1715
5.34 5.56 5.78 6.08 6.38 d
3.74 3.84 3.92 4.07 4.22 d
Table 2 Diabetes prevalence rate by age and gender in Taiwan from 2000 to 2009.
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009*
Women 0e19 years 0.06 0.06 0.06 0.06 0.07 0.07 0.07 0.08 0.08% 0.08
20e39 years 0.45 0.36 0.40 0.41 0.45 0.45 0.47 0.50 0.52 0.50
40e59 years 4.63 4.65 4.81 4.91 5.13 5.24 5.35 5.55 5.70 5.47
60e79 years 17.17 17.76 18.58 19.18 20.03 20.73 21.26 21.86 22.44 21.97
80 years 14.72 15.49 16.62 17.58 19.32 20.32 20.97 22.39 23.63 23.97
All Women 3.34 3.47 3.73 3.94 4.24 4.45 4.65 4.93 5.22 5.24
Men 0e19 years 0.06 0.05 0.05 0.05 0.06 0.06 0.07 0.07 0.08 0.07
20e39 years 0.52 0.51 0.56 0.59 0.65 0.68 0.72 0.76 0.80 0.78
40e59 years 4.97 5.21 5.60 5.89 6.36 6.64 6.90 7.27 7.64 7.56
60e79 years 13.60 14.25 15.19 15.89 16.94 17.73 18.32 19.21 20.04 19.97
80 years 11.66 12.32 13.27 14.19 15.18 16.19 16.92 18.25 19.67 20.07
All Men 3.01 3.20 3.49 3.74 4.08 4.33 4.57 4.89 5.24 5.34
Data are expressed as (%).
* Underestimated due to incomplete follow-up in 2009.
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had regular follow-up, rather than all diabetic patients.
Definition of type 1 diabetes
Type 1 diabetes is considered a catastrophic illness by the
Taiwan NHI. Due to the fact that no co-payment is required
for admission, emergency, or outpatient services, this
certification is only applied when detailed and specific
clinical data are met, e.g., a history of diabetic ketoaci-
dosis, a positive glucagon test, and the presence of
glutamic-acid-decarboxylase (GAD) antibodies. This system
is a strict but reliable method for using a catastrophic
illness certificate as the diagnostic criteria for type 1 dia-
betes. This data included all type 1 DM patients rather than
only one-third.
Prevalence and incidence
For detailed analysis of the diabetic population in Taiwan,
stratification by gender and age group (0e19, 20e39,
40e59, 60e79, and 80 years or older) was performed. For
international comparison, age-standardization according to
the 2000 World Health Organization population statistics
(WHO 2000) was also shown. Because using the data of
patients with incomplete follow-ups would result in
misleading information and may underestimate the inci-
dence and prevalence rates, these data were not shown in
the 2009 data.Table 3 Diabetes incidence rate in Taiwan from 2000 to 2009.
2000 2001 2002 2003
Residents (104) 2228 2241 2252 2261
Total DM (104) 70.7 74.8 81.3 86.8
Incidence (%) 0.764 0.834 0.793 0.79
Incidence (%), 20e79 1.043 1.127 1.052 1.04
Standardized Incidence (%) 0.805 0.865 0.804 0.79
* Underestimated due to incomplete follow-up in 2009.Results
Similar to the global trends in DM, the diabetic population
in Taiwan also increased every year. As seen in Table 1,
there was a nearly 80% increase in the total diabetic pop-
ulation, a 55% increase in the prevalence rate, and a 35%
increase in the age-standardized prevalence rate in the
analysis period.
Prevalence categorized by age group and gender is
shown in Table 2. From 2000 to 2008, the increase in the
prevalence rate was 33% for women under 19 years of age,
15% for women aged 20e39 years, 23% for women aged
40e59 years, 31% for women aged 60e79 years, and 61% for
women aged 80 years and older. For men in the same age
groups, the increases were 33%, 54%, 54%, 47%, and 69%,
respectively. The overall increase in the prevalence from
2000 to 2008 was 56% for women and 74% for men.
Although a 25% increase in the overall diabetes inci-
dence rate was observed (Table 3), the incidence rate for
individuals aged 20e79 years, or the age-standardized
incidence rate, was nearly constant from 2000e2009.
Table 4 shows cases categorized according to age groups
and gender. For children younger than age 19, the lowest
diabetes incidence rate (about 20 new cases) was the same
for both sexes. For the young and middle age groups (aged
20e59 years), there were more DM cases in men than in
women. In the groups aged 60 years and older, more women
than men had DM.
Before 2005, the diabetic population predominantly
included women. However, men became predominant after2004 2005 2006 2007 2008 2009*
2269 2277 2288 2296 2304 2312
94.5 100.0 105.5 112.8 120.5 122.3*
8 0.879 0.831 0.840 0.903 0.932 d
7 1.140 1.060 1.066 1.137 1.160 d
3 0.852 0.790 0.777 0.817 0.823 d
Table 4 Age and gender-specific incidence of new cases of diabetes in Taiwan from 2000 to 2009.
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009*
Women 0e19 years 26 17 19 18 20 18 19 23 20 18
20e39 years 241 157 166 154 177 160 168 173 179 149
40e59 years 1242 1325 1181 1158 1236 1116 1122 1192 1193 970
60e79 years 3430 3889 3480 3454 3633 3521 3424 3550 3554 2889
80 years 3894 4302 4117 4113 4483 4407 4088 4289 4346 3897
All Women 759 813 757 760 829 789 793 848 870 733
Men 0e19 years 27 17 18 16 23 23 22 22 21 20
20e39 years 234 219 221 228 249 233 249 250 258 228
40e59 years 1428 1593 1502 1492 1642 1497 1536 1643 1677 1449
60e79 years 3119 3482 3280 3203 3506 3351 3224 3474 3522 3009
80 years 3134 3357 3377 3407 3583 3559 3447 3646 3864 3417
All Male 766 848 821 827 920 871 885 956 993 873
* Underestimated due to incomplete follow-up in 2009.
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higher than that in women after 2008. In the group younger
than age 19 years, the incidence and prevalence rates were
low for both genders. However, in the groups of age 20e39
and 40e59 years, the incidence and prevalence rates in
men were 10% higher than those in women in 2000 and 40%
higher in 2008 (Tables 2 and 4). In the 60e79 and 80 years or
older age groups, the prevalence in women was still higher,
whereas the incidence in men aged 60e79 was lower in
2000 but equal to that in age-matched women in 2008.
Women aged over 80 years showed a higher incidence rate.
In Taiwan, a catastrophic illness certificate is issued
under strict guidelines. The type 1 diabetic population
accounted for less than 1% of the total diabetic population;
this value may be an underestimate of the actual value but
has remained constant (Table 5). The standardized inci-
dence for type 1 DM seems to fluctuate around 3% but does
not increase (Table 6).Discussion
In this study, by using a more conservative method to avoid
overestimation and the accumulation of false-positive
cases, we reported the prevalence and incidence of dia-
betes in Taiwan from 2000 to 2009. Despite a steady
increase in DM prevalence, the standardized incidence
remained relatively stable for total DM and type 1 diabetes.Table 5 Number of individuals with Type 1 diabetes in Taiwan
2000 2001 2002 2003 2
0e9 years 402 393 366 441 4
10e19 years 1233 1314 1446 1527 1
20e29 years 915 1143 1401 1614 1
30e39 years 714 771 849 1005 1
40e59 years 507 642 762 879 8
60 years 168 186 195 207 1
Type 1 DM, total 3939 4449 5019 5673 5
Total DM (104) 70.7 74.8 81.3 86.8 9
T1DM/All DM (%) 0.56 0.59 0.62 0.65 0
* Underestimated due to incomplete follow-up in 2009.We also reported temporal changes in age- and gender-
specific epidemiological features of DM in Taiwan over
time. The increasing prevalence of DM might be due to
better DM care and lower mortality in recent years.
The NHI was initiated in 1995. We discarded data before
2000 because of the following reasons: (1) NHI coverage
increased to 96% in 2000 (Table 1); (2) a validation study
was performed in 200017; (3) for outpatients presenting
before June 2000, both the ICD-9-CM and A codes were used
(the A code is simpler, but not as accurate); and (4) the
American Diabetes Association revised the DM diagnostic
criteria in 1997 (fasting plasma glucose level, 126 mg/dL),
and added hemoglobin A1c concentration as a criterion in
2009. Therefore, DM diagnostic criteria did not vary from
2000 to 2009 in Taiwan.
From 2000 to 2009, the age-standardized incidence of
diabetes was constant and prevalence increased. However,
the increment in men was higher than that in women. In our
1999e2004 study,18 we found the same phenomenon,
especially in adults aged 20e39. In this study, the data for
a longer period was available, and the overall incidence
rate in men was higher than that in women from 2000 to
2009. There was only a small difference in 2000, but this
difference increased and became increasingly larger over
the years. Therefore, men accounted for the majority of
the diabetic population since 2005, and the prevalence rate
in men became higher since 2008. Why the incidence of
diabetes increased at a higher rate in men than in women isfrom 2000 to 2009.
004 2005 2006 2007 2008 2009
71 489 480 462 411 420
581 1716 1824 1926 1992 1980
764 1935 2070 2151 2307 2439
053 1194 1269 1377 1518 1608
97 1020 1137 1191 1287 1449
44 126 132 129 138 147
910 6480 6912 7236 7653 8043
4.5 100.0 105.5 112.8 120.5 122.3*
.63 0.65 0.66 0.64 0.64 0.66
Table 6 Incidence of type 1 DM in Taiwan from 2000 to 2009. Crude and standardized incidence (per 100,000) of type 1
diabetes were analyzed.
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
0e19 years 4.21 4.31 5.16 5.29 4.48 5.68 5.39 4.28 5.04 5.79
20e39 years 2.93 2.69 3.78 3.60 3.03 3.90 3.10 2.55 11.02 14.18
40e59 years 1.59 1.41 1.61 1.37 1.18 1.58 1.03 0.47 0.94 0.90
60e79 years 2.04 1.52 1.01 0.82 0.97 0.79 0.33 0.22 0.22 0.48
80 years 0.66 0.92 1.13 0.80 0.00 0.46 0.00 0.00 0.00 0.00
Crude incidence 2.79 2.63 3.22 3.09 2.60 3.27 2.70 2.05 2.32 2.64
Standardized Incidence 2.87 2.75 3.36 3.28 2.78 3.56 3.03 2.36 2.70 3.13
Data are expressed as (105).
Diabetes mellitus in Taiwan 603a topic of interest. Although hepatitis C infection was
related to metabolic syndrome in Taiwan, the diabetic
incidence attributable to hepatitis C remained unclear.19
There have been several criteria proposed for type 1
diabetes. In our previous study, we excluded cases of
potential type 1 DM (nZ 41,291).18 Diabetic ketoacidosis is
considered a clinical sign for children but is seldom applied
to adults. Some type 2 or other specific types of DM may
also present with ketoacidosis. Insulin injection was
a common cause of b-cell exhaustion, and the length of the
“honeymoon period” depended on the progression of b-cell
destruction. These criteria were incomplete in the claims
database. All relevant clinical data should be provided in
order to apply for a catastrophic illness certificate,
including type 1 DM. This is a stricter but more reliable way
to define type 1 DM. Underestimation of values could be
expected. Unlike most European countries that show
a 3e4% increase in the type 1 diabetes incidence rate every
year,20 Taiwan showed a consistent incidence rate, partly
influenced by the strict criteria policy for issuing cata-
strophic illness certificates.
The body mass index equivalent was 25 for Chinese and
30 for Caucasian individuals.21 In Taiwan, diabetes risk
scores were developed,22,23 and free health check-ups for
adults older than 40 years of age were started in 1995; early
detection was found to be of great assistance.24 A diag-
nostic protocol was also proposed using fasting plasma
glucose and hemoglobin A1c levels as criteria.25 Then a pay-
for-performance reimbursement program that was based
on the quality of diabetes care, rather than the traditional
payment system based on the quantity of cases, was star-
ted in 2001.26,27 All these programs, such as screening,
diagnosis, treatment, and screening for complications can
detect DM at an earlier stage and improve diabetes
outcomes when performed by a team of certified diabetes
educators in Taiwan.
There are some study limitations. In contrast to our
previous study, which used cumulative DM data, the patient
was considered diabetic forever once he or she was diag-
nosed,18 in this study we chose a more conservative method
to avoid overestimation and the accumulation of false
positive cases over the observed 10 years. We analyzed only
diabetic cases with regular NHI follow-up, rather than
including all diabetic cases. Therefore, the prevalence was
underestimated while the incidence was overestimated.
In conclusion, the present analyses reported the
temporal changes in diabetes prevalence and incidence inTaiwan during 2000e2009. The overall increase of preva-
lence of DM in Taiwan is not due to an increase in incidence,
suggesting a possibility of better diabetes care and
a resulting decrease in mortality rates of individuals with
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